Accessibility Menu
 
TetraLogic Pharmaceuticals logo

TetraLogic Pharmaceuticals

(OTC) TLOG

Current Price$0.00
Market Cap$2,400
Since IPO (2013)-100%
5 Year-100%
1 Year+9,900%
1 Month+9,900%

TetraLogic Pharmaceuticals Financials at a Glance

Market Cap

$2,400

Revenue (TTM)

$0.00

Net Income (TTM)

$45.76M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

9.24 (High)

Price

$0.00

Volume

10,720

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

TLOG News

No articles available.

TLOG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TetraLogic Pharmaceuticals

Industry

Biotechnology

Headquarters

Malvern, PA 19355, US

TLOG Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-75%

Return on Assets

-88%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.40K

Shares Outstanding

24.46M

Volume

10.72K

Short Interest

0.00%

Avg. Volume

1.72K

Financials (TTM)

Gross Profit

$187.99K

Operating Income

$44.99M

EBITDA

$43.15M

Operating Cash Flow

$34.89M

Capital Expenditure

$77.33K

Free Cash Flow

$34.97M

Cash & ST Invst.

$20.41M

Total Debt

$28.28M

TetraLogic Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2016YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.40K

N/A

Market Cap/Employee

$82.76

N/A

Employees

29

N/A

Net Income

$8.63M

+30.9%

EBITDA

$9.18M

+0.6%

Quarterly Fundamentals

Name
Q3 2016YOY CHG

Net Cash

$24.92M

-3532.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$30.79M

+6.9%

Short Term Debt

$0.00

N/A

Return on Assets

-87.64%

N/A

Return on Invested Capital

-74.54%

N/A

Free Cash Flow

$2.79M

+63.7%

Operating Cash Flow

$2.79M

+63.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CALACalithera Biosciences, Inc.
$0.00+0.00%
TNGNQTengion, Inc.
$0.00+0.00%
KLDOKaleido Biosciences, Inc.
$0.00+0.00%
BXRXQBaudax Bio, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%
VRTVertiv
$255.88-0.05%

Questions About TLOG

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.